U.S. flag

An official website of the United States government

NM_000152.5(GAA):c.1123C>T (p.Arg375Cys) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 18, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000780270.2

Allele description [Variation Report for NM_000152.5(GAA):c.1123C>T (p.Arg375Cys)]

NM_000152.5(GAA):c.1123C>T (p.Arg375Cys)

Gene:
GAA:alpha glucosidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_000152.5(GAA):c.1123C>T (p.Arg375Cys)
Other names:
NM_000152.5(GAA):c.1123C>T; p.Arg375Cys
HGVS:
  • NC_000017.11:g.80108536C>T
  • NG_009822.1:g.11981C>T
  • NM_000152.5:c.1123C>TMANE SELECT
  • NM_001079803.3:c.1123C>T
  • NM_001079804.3:c.1123C>T
  • NP_000143.2:p.Arg375Cys
  • NP_001073271.1:p.Arg375Cys
  • NP_001073272.1:p.Arg375Cys
  • LRG_673t1:c.1123C>T
  • LRG_673:g.11981C>T
  • NC_000017.10:g.78082335C>T
  • NM_000152.3:c.1123C>T
Protein change:
R375C
Links:
dbSNP: rs372486238
NCBI 1000 Genomes Browser:
rs372486238
Molecular consequence:
  • NM_000152.5:c.1123C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079803.3:c.1123C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079804.3:c.1123C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000917396Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jul 18, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges.

Schabhüttl M, Wieland T, Senderek J, Baets J, Timmerman V, De Jonghe P, Reilly MM, Stieglbauer K, Laich E, Windhager R, Erwa W, Trajanoski S, Strom TM, Auer-Grumbach M.

J Neurol. 2014 May;261(5):970-82. doi: 10.1007/s00415-014-7289-8. Epub 2014 Mar 15.

PubMed [citation]
PMID:
24627108

Development of a clinically validated in vitro functional assay to assess pathogenicity of novel GAA variants in patients with Pompe disease identified via newborn screening.

Goomber S, Huggins E, Rehder CW, Cohen JL, Bali DS, Kishnani PS.

Front Genet. 2022;13:1001154. doi: 10.3389/fgene.2022.1001154.

PubMed [citation]
PMID:
36246652
PMCID:
PMC9562992
See all PubMed Citations (4)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000917396.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: GAA c.1123C>T (p.Arg375Cys) results in a non-conservative amino acid change located in the Glycoside hydrolase family 31, TIM barrel domain (IPR000322) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 248608 control chromosomes (gnomAD). c.1123C>T has been reported in the literature in newborns who had abnormal newborn screening and also in an individual affected with hyperCKemia (examples : Gemelli_2020, Goomber_2022, Kubaski_2023) . These report(s) do not provide unequivocal conclusions about association of the variant with Glycogen Storage Disease, Type 2 (Pompe Disease). A different variant affecting the same codon has been classified as pathogenic by our lab (c.1124G>T, p.Arg375Leu), supporting the critical relevance of codon 375 to GAA protein function. In an invitro functional study, the variant resulted in reduced activity (Goomber_2022). The following publications have been ascertained in the context of this evaluation (PMID: 34687219, 36246652, 37507255, 24627108). ClinVar contains an entry for this variant (Variation ID: 290225). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024